Objective-To compare percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia.
Introduction
Enteral nutrition with fine bore nasogastric tubes has been used successfully for many years to provide long term nutritional support for patients with dysphagia due to neurological disorders. Elderly patients, however, do not always tolerate nasogastric feeding and self extubation is common. One study found that as many as 23% of nasogastric tubes were unintentionally removed within 24 hours of starting feeding. ' Ciocon et al found that early self extubation occurred in two thirds of elderly patients fed by tube.2 Nasogastric tubes are least well tolerated by patients with stroke, who may require frequent reintubations and close nursing surveillance.3 Reintubation is distressing for the patients and their attendants. Furthermore, long term nasogastric feeding is unaesthetic and the tubes often block. The extra nursing time and occasional need for radiography when replacing tubes all add to the cost of nasogastric tube feeding.
Although surgical gastrostomy is an alternative to nasogastric feeding many clinicians have been reluctant to use this method for fear of associated complications4 and the need for general anaesthesia (up to 25% of cases). (2 9) years) but the difference was not significant (table I) . One patient in each group died after randomisation but before intubation and feeding could be started (one of myocardial-infarction, the other of respiratory arrest). Results are confined to the 38 patients who lived to participate in the study. Table II shows the reasons for failure of treatment. Treatment failure occurred in 18 (95%) of the 19 patients in the nasogastric group but none in the gastrostomy group. All patients in whom nasogastric tube feeding failed elected to switch to gastrostomy tube feeding, which was again successful in all cases.
The liquid diet Ensure (Abbott Laboratories) was used for all patients except for one man in the gastrostomy group who had a history of possible chronic pancreatitis and was given Peptamen (Clintec Nutrition, Slough, United Kingdom). All patients in the gastrostomy group completed 28 days of feeding compared with only one patient in the nasogastric group. The mean (SE) duration of feeding for the nasogastric group was 5-2 (1-5) days (table III) . Although both groups had similar prescribed intakes of liquid diets, the nasogastric group received a significantly lower percentage of their prescribed feed than the gastrostomy group (55% (4%) v 93% (2%); P<o ool).
There were no complications during the short period of feeding in the nasogastric group, but three patients in the gastrostomy group developed minor complications related to the feeding. Two patients had aspiration pneumonia and one a wound infection. All three settled well with appropriate antibiotic treatment. Two patients had delayed gastric emptying during the first three to four days of feeding, one of whom subsequently developed aspiration pneumonia despite slowing of the infusion rate. Motor neurone disease 7 9 Cerebral palsy 1 4 Parkinson's disease I Before the trial the mean (SE) weight for the nasogastric group was higher than that of the gastrostomy group (50 4 (2 5) v 44 0 (3-1) kg), but this difference was not significant. After the first week the gastrostomy group had gained significantly more weight (1) (2) (3) (4) (05) kg) than the nasogastric group (0-6 (0 1) kg; p<005) (table IV). This was the result of the greater dietary intake of the gastrostomy group during this period. After the first week the numbers in the nasogastric group were too small for statistical comparisons. The mean (SE) increase in weight during the study for patients in the gastrostomy group was 3-4 (0 6) kg. Before the trial results for mid-arm muscle circumference and triceps skinfold thickness tests were similar for both groups. During the study there was a slight increase in both parameters. Statistical comparison was again impractical because of the small numbers in the nasogastric group.
Concentrations of haemoglobin, serum albumin, and transferrin; lymphocyte count; and 24 hour urinary nitrogen excretion were similar in each group before entry to the trial. Serum albumin and transferrin concentrations increased in the gastrostomy group from 35 to 38 g/l and 2-3 to 2 6 g/l respectively at four weeks. Statistical analyses were impractical because of the small numbers in the nasogastric group after the first week of the trial.
The single patient who completed four weeks of nasogastric feeding opted for gastrostomy tube feeding at completion of the study. She stated that the nasogastric tube feeding was cosmetically unacceptable. Two other patients refused to continue with feeding by the nasogastric route during the trial.
The 38 patients were followed up for a median of 184 (range 30-390) days. All patients received gastrostomy tube feeding after completion or withdrawal from the trial. Patients ranked their acceptability of gastrostomy tube feeding as excellent (16 patients), very good (21), and fair (one). The gastrostomy tube was removed in three stroke patients whose swallowing had improved after a median duration of 58 days. Two patients required a change of gastrostomy tube at 280 and 325 days.
Discussion
We have shown that percutaneous endoscopic gastrostomy tube feeding is superior to nasogastric tube feeding for the enteral nutritional support of patients with persisting dysphagia resulting from neurological disease. There were no treatment failures in the gastrostomy group, whereas only one patient in the nasogastric group completed four weeks offeeding. The gastrostomy patients received a significantly greater proportion of the prescribed feed and after one week had significantly greater weight gain than the nasogastric patients. The greater weight gain in the gastrostomy group was attributable to the greater dietary intake during uninterrupted feeding.
Treatment failures in the nasogastric group occurred after a mean of 5 2 days, and two thirds ofthese failures were caused by tube dislodgment. These findings agree with previous studies showing displacement rates of 25-67%, most of which are accounted for by self extubation. 2 14 Other complications associated with nasogastric feeding include nasal irritation, oesophagitis, metabolic abnormalities, aspiration pneumonia, pulmonary intubation, and traumatic pneumothorax. 13 Our complete success in insertion of gastrostomy tubes compares favourably with the average success rate of 95% in American studies. '5 16 Recognised complications of gastrostomy tube feeding include gastric perforation, gastric haemorrhage, gastrocolic fistula, infection of stoma site, and aspiration pneumonia.'0 During our study three patients in the gastrostomy group developed complications. One patient developed a stoma site infection which would have been classified as minor by criteria in other studies.4'8 The other two patients developed aspiration pneumonia which responded to standard treatment. Our morbidity of 16% with gastrostomy was in keeping with that in other studies.489 11 12 17 Patients with neurological dysphagia, many of whom are unable to swallow their own saliva, are prone to aspiration pneumonia. The two patients who had aspiration pneumonia during our trial had recovered from similar episodes several weeks before the study. Our study has confirmed earlier reports that gastrostomy tube feeding does not protect against aspiration pneumonia.27'9 Cogen and Weinryb found that a history of aspiration pneumonia was the only risk factor associated with subsequent episodes during gastrostomy feeding; age, mental status, type of liquid diet, or infusion time did not affect the risk of aspiration pneumonia. 19 In conclusion, this study has shown that percutaneous endoscopic gastrostomy tube feeding is a safe, effective, and acceptable method of providing long term enteral nutrition in neurological patients and offers important advantages over standard nasogastric tube feeding. Candidates for gastrostomy tube feeding should need enteral nutrition for more than four to six weeks and have a prognosis which justifias nutritional support. In this group of patients improvement in nutrition can enhance both the quality of life and rehabilitation.20 In our opinion nasogastric tube feeding should be used for only short term nutritional support.
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Introduction
Throughout the United Kingdom during the 1960s and early 1970s the number of hospital referrals for deliberate self poisoning and self injury (attempted suicide) rose greatly, especially in young women.'`3 Deliberate self poisoning (overdose) became especially common, such that by the mid-1970s it was the most common reason for emergency medical admissions of women to hospital and the second most common such reason for men.4 This paper reviews trends in referrals for attempted suicide to the general hospital in Oxford over the 15 years 1976-90 and is based on information collected in a computerised monitoring system.5
Method
We studied the attempts of people aged 15 
